Chen et al. and Zhang et al. reported that higher expression of FDX1 was associated with a better prognosis of renal clear cell carcinoma and could be used as a potential prognostic indicator and therapeutic target for ccRCC [53, 54]. The gene discussed is FDX1; the disease is clear cell renal carcinoma.